Tomassetti S, Gurioli C, Ryu JH, De Biase D, Ravaglia C, Tantalocco P, et al. The impact of lung cancer on survival of idiopathic pulmonary fibrosis. Chest. 2015;147:157–64.

Article  PubMed  Google Scholar 

Kenmotsu H, Naito T, Kimura M, Ono A, Shukuya T, Nakamura Y, et al. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol. 2011;6:1242–6.

Article  PubMed  Google Scholar 

Ueki N, Matsuo Y, Togashi Y, Mizowaki T, Nakamura M, Ishii K, et al. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol. 2015;10:116–25.

Article  CAS  PubMed  Google Scholar 

Ikeda S, Misumi T, Kato T, Okamoto H, Ogura T. Immune checkpoint inhibitor-induced pneumonitis in patients with non-small cell lung cancer and preexisting interstitial lung diseases: really mild and easily manageable? Chest. 2022;162:e65–6.

Article  CAS  PubMed  Google Scholar 

Sato T, Teramukai S, Kondo H, Watanabe A, Watanabe T, Yokoi K, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147:1604-11.e3.

Article  PubMed  Google Scholar 

Sato T, Kondo H, Watanabe A, Okubo K, Yokoi K, Nakagawa K. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015;63:164–72.

Article  PubMed  Google Scholar 

Kanayama M, Osaki T, Nishizawa N, Nakagawa M, So T, Kodate M. Modified risk scoring system for acute exacerbation of interstitial lung disease. Asian Cardiovasc Thorac Ann. 2019;27:18–22.

Article  PubMed  Google Scholar 

Sato T, Watanabe A, Kondo H, Yokoi K, Nakagawa K, Okubo K, et al. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. J Thorac Cardiovasc Surg. 2015;149:64–9.

Article  PubMed  Google Scholar 

Iwata T, Yoshida S, Fujiwara T, Matsumoto S, Matsuno Y, Miyamoto Y. Effect of perioperative pirfenidone treatment in lung cancer patients with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2016;102:1905–10.

Article  PubMed  Google Scholar 

Kanayama M, Mori M, Matsumiya H, Yamamoto Y, Inoue M, Tsubochi H. Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis. Surg Today. 2020;50:469–74.

Article  PubMed  Google Scholar 

Sakairi Y, Yoshino I, Iwata T, Tsuboi M, Okada M, Yano T, et al. A randomized controlled phase III trial protocol: perioperative pirfenidone therapy in patients with non-small cell lung cancer combined with idiopathic pulmonary fibrosis. J Thorac Dis. 2023;15:1486–93.

Article  PubMed  PubMed Central  Google Scholar 

Tsutani Y, Mimura T, Kai Y, Kobayashi M, Matsui H, Nishikubo M. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg. 2017;154:1089-96.e1.

Article  PubMed  Google Scholar 

Tanaka K, Tsutani Y, Wakabayashi M, Kobayashi M, Matsui H, Oizumi H, et al. Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis. Jpn J Clin Oncol. 2020;50:1076–9.

Article  PubMed  Google Scholar 

Huang J, Osarogiagbon RU, Giroux DJ, Nishimura KK, Bille A, Cardillo G, et al. The international association for the study of lung cancer staging project for lung cancer: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer. J Thorac Oncol. 2024;19:766–85.

Article  PubMed  Google Scholar 

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

Article  PubMed  PubMed Central  Google Scholar 

Raghu G, Remy-Jardin M, Richeldi L, Thompson BT, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official clinical practice guideline. Am J Respir Crit Care Med. 2022;205:e18-47.

Article  PubMed  PubMed Central  Google Scholar 

Collard HR, Ryerson CJ, Corte TJ, Richeldi L, Inoue Y, Molina-Molina M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: an international working group report. Am J Respir Crit Care Med. 2016;194:265–77.

Article  CAS  PubMed  Google Scholar 

Okami J, Shintani Y, Okumura M, Aokage K, Tsuboi M, Asamura H, et al. Demographics, safety and quality, and prognostic information in TNM classifications in 18,973 cases. J Thorac Oncol. 2019;14:212–22.

Article  PubMed  Google Scholar 

Ki MS, Kim SY, Kim EY, Lee J, Chung MP, Park K. Clinical outcomes and prognosis of patients with interstitial lung disease undergoing lung cancer surgery. Clin Lung Cancer. 2023;24:e27-38.

Article  PubMed  Google Scholar 

Alomaish H, Ung Y, Wang S, Tyrrell PN, Zahra SA, Oikonomou A. Survival analysis in lung cancer patients with interstitial lung disease. PLoS ONE. 2021;16:e0255375.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asano F, Aoe M, Ohsaki Y, Okada Y, Sasada S, Sato S, et al. Deaths and complications associated with respiratory endoscopy: a survey by the Japan Society for Respiratory Endoscopy in 2010. Respirology. 2012;17:478–85.

Article  PubMed  Google Scholar 

Azuma Y, Sakamoto S, Homma S, Sakai T, Koezuka S, Kamemura M, et al. Impact of partial pressure of arterial oxygen and radiologic findings on postoperative acute exacerbation of idiopathic interstitial pneumonia in patients with lung cancer. Surg Today. 2024;54:122–9.

Article  CAS  PubMed  Google Scholar 

Choi JS, Choi JH, Kim YM, Nam HS, Lee SH, Yoo H, et al. Risk factors for predicting hypoxia in adult patients undergoing bronchoscopy under sedation. Tuberc Respir Dis. 2020;83:312–21.

Article  Google Scholar 

Bergbower EAS, Papadimos TJ, Morris MJ, Phillips GS, Jones GM, Oleson AM, et al. A retrospective analysis of respiratory complications under general anesthesia during EBUS-TBNA. J Community Hosp Intern Med Perspect. 2022;12:19–27.

Article  PubMed  PubMed Central  Google Scholar 

Xiaohong X, Liqiang W, Na L, Ying Z, Yingxue Y, Yuhui Z, et al. Management and prognosis of interstitial lung disease with lung cancer (ILD-LC). Front Mol Biosci. 2021;8:660800.

Article  PubMed  PubMed Central  Google Scholar 

Udelsman BV, Madariaga ML, Chang DC, Kozower BD, Gaissert HA. Concordance of clinical and pathologic nodal staging in resectable lung cancer. Ann Thorac Surg. 2021;111:1125–32.

Article  PubMed  Google Scholar 

Fujita T, Kuroki T, Hayama N, Takahashi Y, Hara M, Yamada T. Pemetrexed plus platinum for advanced non-small cell lung cancer and interstitial lung disease. In Vivo. 2019;33:2059–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kenmotsu H, Yoh K, Mori K, Kubo T, Tamiya A, Shimizu J, et al. Phase II study of nab-paclitaxel plus carboplatin in NSCLC and ILD. Cancer Sci. 2019;110:3738–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Igawa S, Nishinarita N, Takakura A, Yamada K, Maeda Y, Tamura T. Real-world evaluation of carboplatin plus weekly nab-paclitaxel in NSCLC with ILD. Cancer Manag Res. 2018;10:7013–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Otsubo K, Kishimoto J, Ando M, Kimura H, Sakata T, Sato Y, et al. Nintedanib plus chemotherapy for NSCLC with idiopathic pulmonary fibrosis. Eur Respir J. 2022;60:2200369.

Article  Google Scholar